Literature DB >> 8831497

Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells.

M R Slowik1, L G De Luca, W Min, J S Pober.   

Abstract

Tumor necrosis factor (TNF) activates transcription of endothelial leukocyte adhesion molecule-1 (CD62E) in endothelial cells (ECs) through the binding to the gene promoter of the p50/p65 heterodimeric form of nuclear factor-kappa B (NF-kappa B) and of the N-terminal phosphorylated form of the ATF2/c-Jun transcription factor, which is phosphorylated by Jun N-terminal kinase (JNK). However, the intracellular signaling pathways that activate endothelial NF-kappa B and JNK in TNF-induced responses are unknown. In this study we have examined the role of a recently described TNF signaling pathway involving sphingomyelin activation to generate ceramide, a potential intracellular mediator. We find that concentrations of TNF that strongly activate NF-kappa B and JNK within 15 minutes do not produce either a measurable decline in sphingomyelin or a measurable generation of ceramide in cultured human umbilical vein ECs at any time examined. Stimulation of ECs with purified sphingomyelinase (SMase) enzyme causes a rapid 60% to 80% decrease in cellular sphingomyelin content and a large increase in ceramide. However, SMase treatment only minimally activates NF-kappa B, achieving levels that are insufficient to initiate gene transcription. Extracellular SMase does not have access to intracellular sphingomyelin, but treatment of ECs with membrane-permeant ceramide analogues still completely fails to activate NF-kappa B and only activates JNK at late times. Neither SMase nor ceramide analogues induce gene transcription or surface expression of endothelial leukocyte adhesion molecules that are readily induced by TNF. Strikingly, low concentrations of membrane-permeant ceramide cause programmed cell death in ECs, a finding not observed at any concentrations of TNF tested. We conclude that ceramide is not an important second messenger for TNF signaling of gene transcription in ECs but may be a second messenger for cell death in response to as-yet-unidentified signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831497     DOI: 10.1161/01.res.79.4.736

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  17 in total

Review 1.  Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Authors:  Hui Chen; Annie Y Chan; Donald U Stone; Nawajes A Mandal
Journal:  Surv Ophthalmol       Date:  2013-09-05       Impact factor: 6.048

Review 2.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

3.  Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.

Authors:  M E Gerritsen; C P Shen; C A Perry
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload.

Authors:  Yi Zhang; Yan Huang; Anna Cantalupo; Paula S Azevedo; Mauro Siragusa; Jacek Bielawski; Frank J Giordano; Annarita Di Lorenzo
Journal:  JCI Insight       Date:  2016-04-21

Review 5.  Involvement of ceramide in cell death responses in the pulmonary circulation.

Authors:  Irina Petrache; Daniela N Petrusca; Russell P Bowler; Krzysztof Kamocki
Journal:  Proc Am Thorac Soc       Date:  2011-11

6.  Ceramide alters endothelial cell permeability by a nonapoptotic mechanism.

Authors:  Karsten Lindner; Ulrike Uhlig; Stefan Uhlig
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

7.  Smoking exposure induces human lung endothelial cell adaptation to apoptotic stress.

Authors:  Daniela N Petrusca; Mary Van Demark; Yuan Gu; Matthew J Justice; Adriana Rogozea; Walter C Hubbard; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2014-03       Impact factor: 6.914

8.  In vivo formation of complex microvessels lined by human endothelial cells in an immunodeficient mouse.

Authors:  J S Schechner; A K Nath; L Zheng; M S Kluger; C C Hughes; M R Sierra-Honigmann; M I Lorber; G Tellides; M Kashgarian; A L Bothwell; J S Pober
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

9.  Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway.

Authors:  P Xia; J R Gamble; K A Rye; L Wang; C S Hii; P Cockerill; Y Khew-Goodall; A G Bert; P J Barter; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Regulation of arterial-venous differences in tumor necrosis factor responsiveness of endothelial cells by anatomic context.

Authors:  Meng Liu; Martin S Kluger; Alessio D'Alessio; Guillermo García-Cardeña; Jordan S Pober
Journal:  Am J Pathol       Date:  2008-02-21       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.